» Articles » PMID: 36324752

Influence of Hypertension Duration and Blood Pressure Levels on Cardiovascular Disease and All-cause Mortality: A Large Prospective Cohort Study

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objects: A longer duration of hypertension (HTN) has been suggested to be associated with a greater risk of cardiovascular disease (CVD). Whether such an association is similar for mortality risk, and whether HTN duration is associated with CVD/mortality beyond blood pressure (BP) control levels are yet to be assessed. We aimed to examine the associations of HTN duration and the combination of HTN duration and systolic blood pressure (SBP)/diastolic blood pressure (DBP) with risks of CVD and all-cause mortality.

Methods: We used data on ∼450,000 UK residents. Participants were categorized by HTN status and HTN duration. The primary outcome was a composite of non-fatal myocardial infarction, non-fatal stroke and CVD death. We also explored the results for the above-mentioned CVD outcomes separately. All-cause mortality was also used as a secondary outcome. The age at HTN diagnosis was obtained by self-report. HTN duration was calculated as baseline age minus age at diagnosis.

Results: Among all participants, compared with non-hypertensive participants, those with a longer HTN duration had increased risks of CVD and all-cause mortality. These associations persisted among hypertensive patients. Specifically, compared with patients with HTN durations of < 5 y, patients with a HTN duration of 5 to < 10 y, 10 to < 15 y, and ≥ 15 y had adjusted HRs (95% CI) of 1.09 (1.03, 1.17), 1.21 (1.13, 1.31), and 1.38 (1.29, 1.48) for composite CVD (-trend < 0.001); and 1.03 (0.97, 1.08), 1.09 (1.02, 1.16), and 1.17 (1.11, 1.24) for all-cause mortality (-trend < 0.001). When compared with hypertensive patients with BP < 140/90 mmHg and a HTN duration of < 5 y, adjusted HRs of CVD and all-cause mortality were 1.35 (1.15, 1.57) and 1.26 (1.11, 1.42) for those with BP < 140/90 mmHg and a duration of ≥ 15 y, and 1.43 (1.26, 1.60) and 1.13 (1.03, 1.25) for those with BP ≥ 140/90 mmHg and durations of ≥ 15 y, respectively.

Conclusion: A longer HTN duration was associated with increased risks of CVD and overall death in a linear fashion, and these associations were independent of BP control levels.

Citing Articles

Predicting new-onset stroke with machine learning: development of a model integrating traditional Chinese and western medicine.

Wang L, Shi J, Miao L, Chen Y, Wei J, Jia M Front Pharmacol. 2025; 16:1546878.

PMID: 40061953 PMC: 11885310. DOI: 10.3389/fphar.2025.1546878.


Sex Differences in the Impact of BMI on Length of Hospital Stay in Hypertensive Patients Admitted to a Cardiology Department: A Retrospective Cohort Study.

Lokiec K, Uchmanowicz B, Kwasny A, Kubielas G, Smereka J, Surma S Vasc Health Risk Manag. 2024; 20:579-591.

PMID: 39735721 PMC: 11681817. DOI: 10.2147/VHRM.S490795.


A nomogram based on endothelial function and conventional risk factors predicts coronary artery disease in hypertensives.

Huang X, Lin J, Huang X, Zhou T, Xie L BMC Cardiovasc Disord. 2023; 23(1):217.

PMID: 37118701 PMC: 10148409. DOI: 10.1186/s12872-023-03235-6.

References
1.
Lv Y, Gao X, Yin Z, Chen H, Luo J, Brasher M . Revisiting the association of blood pressure with mortality in oldest old people in China: community based, longitudinal prospective study. BMJ. 2018; 361:k2158. PMC: 5987177. DOI: 10.1136/bmj.k2158. View

2.
Ma H, Li X, Sun D, Zhou T, Ley S, Gustat J . Association of habitual glucosamine use with risk of cardiovascular disease: prospective study in UK Biobank. BMJ. 2019; 365:l1628. PMC: 6515311. DOI: 10.1136/bmj.l1628. View

3.
Nuotio J, Suvila K, Cheng S, Langen V, Niiranen T . Longitudinal blood pressure patterns and cardiovascular disease risk. Ann Med. 2020; 52(3-4):43-54. PMC: 7877994. DOI: 10.1080/07853890.2020.1733648. View

4.
Malden D, Lacey B, Emberson J, Karpe F, Allen N, Bennett D . Body Fat Distribution and Systolic Blood Pressure in 10,000 Adults with Whole-Body Imaging: UK Biobank and Oxford BioBank. Obesity (Silver Spring). 2019; 27(7):1200-1206. PMC: 6618903. DOI: 10.1002/oby.22509. View

5.
Niiranen T, McCabe E, Larson M, Henglin M, Lakdawala N, Vasan R . Heritability and risks associated with early onset hypertension: multigenerational, prospective analysis in the Framingham Heart Study. BMJ. 2017; 357:j1949. PMC: 5430541. DOI: 10.1136/bmj.j1949. View